Earnings · China A-shares
Hubei Guangji Pharmaceutical Co., Ltd Class A (000952) earnings
Hubei Guangji Pharmaceutical Co., Ltd Class A published its Q3 report on 2026-10-29: net profit +38.43% year on year, +14.17% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -2.43% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- +38.43%
- Excl. one-offs YoY
- +14.17%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.30% | — |
| 3 days | -2.43% | — |
| 7 days | -3.13% | — |
| 14 days | -6.78% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 2 of 6 reports (average +1.13%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | -¥59.91M | +38.43% | +14.17% | +1.44% | -0.17 | -9.55% | -2.43% | — | — |
| 2026 interim report | 2026-08-28 | -¥57.95M | +23.27% | +16.35% | +9.71% | -0.17 | -9.27% | -0.30% | -3.16% | +6.54% |
| 2026 Q1 report | 2026-04-25 | -¥31.64M | +12.75% | +12.26% | +9.84% | -0.09 | -4.96% | +8.83% | -8.08% | -7.78% |
| 2025 annual report | 2026-04-25 | -¥404.49M | -36.98% | -36.07% | -2.32% | -1.16 | -47.20% | +8.83% | -8.08% | -7.78% |
| 2025 Q3 report | 2025-10-27 | -¥97.30M | +38.64% | +40.89% | -7.12% | -0.28 | -9.54% | -3.15% | +18.77% | +18.99% |
| 2025 interim report | 2025-08-29 | -¥75.52M | +29.19% | +32.21% | -4.08% | -0.22 | -7.27% | -0.15% | -4.38% | -5.66% |
| 2025 Q1 report | 2025-04-28 | -¥36.27M | +28.20% | +34.71% | -17.58% | -0.10 | -3.46% | +3.98% | +18.37% | +15.13% |
| 2024 annual report | 2025-04-28 | -¥295.29M | -110.55% | — | -13.42% | -0.84 | -24.43% | +3.98% | +18.37% | +15.13% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.